Keine Treffer zu Ihrer Suche. Versuchen Sie es mit einem anderen Suchbegriff oder stöbern durch unsere Angebote:

Stöbern Sie durch unsere Angebote (75 Treffer)

Kategorien [Filter löschen]

Shops

Umbelliprenin and Chronic Lymphocytic Leukemia ...
21,99 € *
ggf. zzgl. Versand

Chronic Lymphocytic Leukemia (CLL) is the most common type of leukemia in western countries. One of the most important strategies in CLL chemotherapy is apoptosis induction in CLL cells. Over the last decades herbal medicines and their constituents attract the attentions for chemotherapy of CLL. Umbelliprenin is a sesquiterpene coumarin, that is synthesized by various Ferula species. Apoptosis induction and cytotoxicity toward cancerous cells by umbelliprenin, firstly showed in 2008. In my Ph.D thesis I studied the properties of apoptosis induction in CLL cell lines by umbelliprenin. For the first time I should that umbelliprenin could induce apoptosis in CLL cell lines time- and dose- dependently. umbelliprenin and other natural coumarins are hopeful compounds in the future of CLL chemotherapy.

Anbieter: Dodax
Stand: 24.01.2020
Zum Angebot
Umbelliprenin and Chronic Lymphocytic Leukemia ...
29,80 € *
ggf. zzgl. Versand

Chronic Lymphocytic Leukemia (CLL) is the most common type of leukemia in western countries. One of the most important strategies in CLL chemotherapy is apoptosis induction in CLL cells. Over the last decades herbal medicines and their constituents attract the attentions for chemotherapy of CLL. Umbelliprenin is a sesquiterpene coumarin, that is synthesized by various Ferula species. Apoptosis induction and cytotoxicity toward cancerous cells by umbelliprenin, firstly showed in 2008. In my Ph.D thesis I studied the properties of apoptosis induction in CLL cell lines by umbelliprenin. For the first time I should that umbelliprenin could induce apoptosis in CLL cell lines time- and dose- dependently. umbelliprenin and other natural coumarins are hopeful compounds in the future of CLL chemotherapy.

Anbieter: Dodax AT
Stand: 24.01.2020
Zum Angebot
Responses of CLL cells to purine analogs with c...
21,99 € *
ggf. zzgl. Versand

Our findings demonstrate the need of ex vivo chronic lymphocytic leukemia cell (CLL) treatment before the application of drugs to select the most efficient manner of the patient s therapy. The obtained results confirm the link between the outcomes of the research done under ex vivo and in vivo conditions and underline the usefulness of ex vivo studies in the individual choice of CLL treatment. Our observations provide a base for further studies on the relationship between the in vivo clinical responses of patients and ex vivo pro-apoptotic activity, and the cytotoxicity of drugs against leukemic cells. Their validation by a study comprising a much larger group of patients is needed.

Anbieter: Dodax AT
Stand: 24.01.2020
Zum Angebot
Responses of CLL cells to purine analogs with c...
21,99 € *
ggf. zzgl. Versand

Our findings demonstrate the need of ex vivo chronic lymphocytic leukemia cell (CLL) treatment before the application of drugs to select the most efficient manner of the patient s therapy. The obtained results confirm the link between the outcomes of the research done under ex vivo and in vivo conditions and underline the usefulness of ex vivo studies in the individual choice of CLL treatment. Our observations provide a base for further studies on the relationship between the in vivo clinical responses of patients and ex vivo pro-apoptotic activity, and the cytotoxicity of drugs against leukemic cells. Their validation by a study comprising a much larger group of patients is needed.

Anbieter: Dodax
Stand: 24.01.2020
Zum Angebot
Advances in Chronic Lymphocytic Leukemia
186,99 € *
ggf. zzgl. Versand

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course. While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL. In this book, CLL experts have contributed state-of-the-art summaries of various important aspects of CLL biology and have discussed the translational implication of such findings. This book, which is directed at physicians and researchers alike, aims to educate broadly and deeply. Intentionally, the many aspects and nuances of CLL clinical care that can only really be appreciated through direct patient care are not covered here, but instead, the book presents basic aspects of CLL that underlie many of the contemporary decisions that are made in CLL research and clinical settings.We hope that this book will critically inform the community and stimulate interest in CLL, which will ultimately translate into better CLL research, prognostication and therapy, with the end goal of providing a better outlook for patients afflicted with this common leukemia.

Anbieter: Dodax AT
Stand: 24.01.2020
Zum Angebot
Advances in Chronic Lymphocytic Leukemia
181,89 € *
ggf. zzgl. Versand

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course. While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL. In this book, CLL experts have contributed state-of-the-art summaries of various important aspects of CLL biology and have discussed the translational implication of such findings. This book, which is directed at physicians and researchers alike, aims to educate broadly and deeply. Intentionally, the many aspects and nuances of CLL clinical care that can only really be appreciated through direct patient care are not covered here, but instead, the book presents basic aspects of CLL that underlie many of the contemporary decisions that are made in CLL research and clinical settings.We hope that this book will critically inform the community and stimulate interest in CLL, which will ultimately translate into better CLL research, prognostication and therapy, with the end goal of providing a better outlook for patients afflicted with this common leukemia.

Anbieter: Dodax
Stand: 24.01.2020
Zum Angebot
Chronische lymphatische Leukämie
5,10 € *
ggf. zzgl. Versand

Seit Erscheinen der ersten Auflage wurden auf dem Gebiet der chronischen lymphatischen Leukämie (CLL) erhebliche Fortschritte erzielt. Wesentliche pathogenetische Erkenntnisse und besonders die Erweiterung und Verbesserung des therapeutischen Spektrums machten eine Neuauflage erforderlich. In der vorliegenden 2. Auflage fassen führende Experten das aktuelle Wissen zur CLL zusammen. Ausgehend von den molekulargenetischen Grundlagen über die klinischen Symptome, Komplikationen und Begleiterkrankungen sowie die Diagnostik liegt der Schwerpunkt des Buches bei den verschiedenen Therapieoptionen der CLL. Detailliert wird auf die einzelnen bei der CLL wirksamen Substanzen und Kombinationstherapien eingegangen, Strategien und Indikationen zur Primär- und Rezidivbehandlung verschiedener Patientenkollektive werden aufgezeigt. Die Ergebnisse der autologen Stammzelltransplantation und der Ausblick auf innovative Therapieansätze runden das Lehrbuch ab.

Anbieter: Dodax AT
Stand: 24.01.2020
Zum Angebot
Laporte, Maxime: LA PROTHE`SE DE CHEVILLE AKILE...
59,00 € *
ggf. zzgl. Versand

Erscheinungsdatum: 05/2010, Medium: Taschenbuch, Einband: Kartoniert / Broschiert, Titel: LA PROTHE`SE DE CHEVILLE AKILE CLL, Titelzusatz: ÉTUDE PROSPECTIVE, A` PROPOS DE 60 CAS, Autor: Laporte, Maxime, Verlag: Editions universitaires europeennes EUE, Sprache: Französisch, Rubrik: Medizin // Andere Fachgebiete, Seiten: 164, Informationen: Paperback, Gewicht: 261 gr, Verkäufer: averdo

Anbieter: averdo
Stand: 24.01.2020
Zum Angebot
Chronische lymphatische Leukämie
4,95 € *
ggf. zzgl. Versand

Seit Erscheinen der ersten Auflage wurden auf dem Gebiet der chronischen lymphatischen Leukämie (CLL) erhebliche Fortschritte erzielt. Wesentliche pathogenetische Erkenntnisse und besonders die Erweiterung und Verbesserung des therapeutischen Spektrums machten eine Neuauflage erforderlich. In der vorliegenden 2. Auflage fassen führende Experten das aktuelle Wissen zur CLL zusammen. Ausgehend von den molekulargenetischen Grundlagen über die klinischen Symptome, Komplikationen und Begleiterkrankungen sowie die Diagnostik liegt der Schwerpunkt des Buches bei den verschiedenen Therapieoptionen der CLL. Detailliert wird auf die einzelnen bei der CLL wirksamen Substanzen und Kombinationstherapien eingegangen, Strategien und Indikationen zur Primär- und Rezidivbehandlung verschiedener Patientenkollektive werden aufgezeigt. Die Ergebnisse der autologen Stammzelltransplantation und der Ausblick auf innovative Therapieansätze runden das Lehrbuch ab.

Anbieter: Dodax
Stand: 24.01.2020
Zum Angebot